GlassScriptPhysician profile
John H Lucas
NPI 1679571020
$31,223.38
in general payments reported to CMS, 2019-2025
83 companies · $5,704 in 2025
The $5,704 reported for 2025 was more than what 86% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,698 · 2020: $2,968 · 2021: $3,530 · 2022: $4,884 · 2023: $4,884 · 2024: $5,556 · 2025: $5,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,143.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $2,968.56 | 2019-2025 | Nuplazid |
| Ucb, INC. | $2,527.16 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Teva Pharmaceuticals USA, INC. | $2,223.65 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Novartis Pharmaceuticals Corporation | $2,042.32 | 2019-2025 | |
| Abbvie INC. | $1,886.93 | 2021-2025 | |
| Biogen, INC. | $1,208.18 | 2019-2025 | Vumerity, Tysabri, Leqembi |
| Neurocrine Biosciences, INC. | $961.81 | 2019-2025 | Ingrezza, Ongentys |
| Mdd US Operations, LLC | $892.39 | 2019-2025 | Gocovri, Myobloc, Apokyn |
| Emd Serono, INC. | $886.94 | 2019-2025 | Mavenclad, Mavenclad |
| Tg Therapeutics, INC. | $835.61 | 2023-2025 | |
| Pfizer INC. | $803.68 | 2021-2025 | |
| Amgen INC. | $789.02 | 2019-2025 | Uplizna, Aimovig |
| Sk Life Science, INC. | $783.72 | 2020-2024 | |
| Genzyme Corporation | $688.07 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $637.70 | 2019-2025 | Ultomiris, Soliris |
Show all 83 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $581.98 | 2019-2025 | Vyepti, Rexulti |
| Amneal Pharmaceuticals LLC | $543.27 | 2019-2025 | Crexont, Rytary, Lyvispah |
| Janssen Pharmaceuticals, INC | $500.71 | 2021-2025 | Spravato |
| Celgene Corporation | $487.09 | 2021-2025 | Zeposia |
| Kyowa Kirin, INC. | $469.05 | 2019-2024 | Nourianz |
| Argenx US, INC. | $441.52 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Sunovion Pharmaceuticals INC. | $438.70 | 2019-2022 | |
| Csl Behring | $433.14 | 2019-2025 | Hizentra |
| Eisai INC. | $423.28 | 2019-2025 | |
| Lilly USA, LLC | $380.34 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Otsuka America Pharmaceutical, INC. | $343.49 | 2023-2025 | Rexulti, Nuedexta |
| Biohaven Pharmaceuticals, INC. | $311.42 | 2020-2021 | |
| Acorda Therapeutics, INC | $309.99 | 2019-2024 | Inbrija |
| Genentech USA, INC. | $300.37 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Axsome Therapeutics, INC. | $284.16 | 2023-2025 | Symbravo, Auvelity, Sunosi |
| Supernus Pharmaceuticals, INC. | $280.51 | 2019-2025 | Qelbree |
| Biohaven Pharmaceutical Holding Company LTD. | $276.82 | 2022 | |
| Banner Life Sciences, LLC | $221.26 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $217.81 | 2023-2025 | Hyqvia |
| Vanda Pharmaceuticals INC. | $215.40 | 2021-2025 | Ponvory, Hetlioz |
| Sumitomo Pharma America, INC. | $198.83 | 2023 | Aptiom |
| Adamas Pharmaceuticals, INC. | $197.52 | 2019-2021 | |
| Assertio Therapeutics, INC. | $186.16 | 2019-2020 | |
| Catalyst Pharmaceuticals, INC. | $171.16 | 2020-2025 | Fycompa |
| Upsher-Smith Laboratories LLC | $158.02 | 2019-2020 | |
| Amylyx Pharmaceuticals, INC. | $148.67 | 2023-2024 | Relyvrio |
| Allergan, INC. | $141.89 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $134.57 | 2022-2025 | Inbrija, Xeomin, Ampyra |
| Bausch Health US, LLC | $123.31 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $113.13 | 2020-2022 | |
| Tanabe Pharma America, INC. | $111.93 | 2019-2025 | Radicava |
| Ge Healthcare | $110.01 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $109.23 | 2021-2025 | Wainua |
| Akcea Therapeutics, INC. | $103.44 | 2019-2020 | |
| Grifols USA, LLC | $99.76 | 2019-2025 | Gamunex-C |
| Boston Scientific Corporation | $98.98 | 2019-2025 | Wavewriter Alpha Prime 16, Watchman Flx |
| Mallinckrodt Enterprises LLC | $97.69 | 2019 | |
| Currax Pharmaceuticals LLC | $94.96 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $92.95 | 2020-2025 | Acthar |
| Medtronic, INC. | $92.74 | 2022-2025 | Intellis Adaptivestim |
| Alnylam Pharmaceuticals INC. | $87.50 | 2021-2025 | Onpattro |
| Impel Pharmaceuticals INC. | $73.57 | 2022-2023 | Trudhesa |
| Scilex Pharmaceuticals INC. | $67.94 | 2023-2024 | Ztlido |
| E.R. Squibb & Sons, L.L.C. | $60.22 | 2024-2025 | Cobenfy, Zeposia |
| Abbott Laboratories | $59.06 | 2023-2025 | Infinity, Amplatzer Talisman |
| Bayer Healthcare Pharmaceuticals INC. | $52.07 | 2019 | |
| Neurelis, INC. | $51.51 | 2025 | Valtoco |
| Avion Pharmaceuticals | $51.37 | 2022-2023 | Dhivy |
| Almatica Pharma LLC | $49.40 | 2021 | |
| Jazz Pharmaceuticals INC. | $46.83 | 2022-2025 | |
| Idorsia Pharmaceuticals US INC | $46.77 | 2023-2024 | Quviviq |
| Ultragenyx Pharmaceutical INC. | $42.03 | 2023-2025 | Dojolvi |
| Xeris Pharmaceuticals, INC. | $40.42 | 2024-2025 | Keveyis |
| Ipsen Biopharmaceuticals, INC | $39.53 | 2022 | |
| Averitas Pharma INC. | $29.96 | 2025 | Qutenza |
| Ani Pharmaceuticals, INC. | $28.48 | 2025 | Purified Cortrophin Gel |
| Hospira, INC. | $25.85 | 2022 | |
| Noctrix Health, INC. | $22.96 | 2024 | Nidra |
| Promius Pharma LLC | $20.92 | 2019 | |
| Aquestive Therapeutics, INC. | $20.63 | 2021 | |
| Insightec,INC | $19.08 | 2025 | Exablate |
| Horizon Therapeutics Plc | $19.00 | 2023 | Uplizna |
| Cala Health, INC. | $17.92 | 2022 | |
| Springworks Therapeutics, INC. | $17.15 | 2025 | Gomekli |
| Sanofi-Aventis U.S. LLC | $14.34 | 2021 | |
| Medtronic Vascular, INC. | $13.63 | 2020 | |
| Alfasigma USA, INC. | $13.29 | 2021 | |
| Zyla Life Sciences, INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
Nuplazid $2,177Briumvi $836Kesimpta $786Qulipta $709Gocovri $619Ubrelvy $606Nurtec Odt $546Austedo Xr $535Briviact $520Ingrezza $517Zavzpret $430Ultomiris $410Rexulti $337Rystiggo $325Nayzilam $316Leqembi $311Botox $310Vumerity $252Uplizna $239Zeposia $233Vyepti $223Panzyga $212Aptiom $199Nourianz $198Vyvgart Hytrulo $198Qelbree $192Vyvgart $191Inbrija $186Tysabri $177Kisunla $176Spravato $173Fycompa $171Hizentra $167Relyvrio $149Symbravo $147Nuedexta $144Amyvid $123Duopa $122Hyqvia $115Vyalev $114Octagam Immune Globulin (Human) $110Mavenclad $109Auvelity $103Crexont $97.39Ongentys $96.44Wainua $92.94Ocrevus $91.90Gamunex-C $86.78Radicava $77.60Rytary $76.71Bafiertam $74.87Xeomin $69.43Leqvio $64.56Trudhesa $61.41Paxlovid $60.95Comirnaty $60.95Lyvispah $60.29Intellis Adaptivestim $60.02Radicava Ors $59.43Emgality $57.04Ponvory $54.93Wavewriter Alpha Prime 16 $53.02Valtoco $51.51Elyxyb - Celecoxib $46.91Quviviq $46.77Ocrevus Zunovo $46.67Enspryng $45.68Keveyis $40.42Onpattro $40.00Sunosi $34.67Cobenfy $34.48Hetlioz $33.65Infinity $32.75Epidiolex $31.59Watchman Flx $31.36Qutenza $29.96Purified Cortrophin Gel $28.48Dojolvi $26.50Amplatzer Talisman $26.31Ampyra $24.44Reyvow $24.11Vraylar $23.29Nidra $22.96Acthar $22.63Soliris $21.83Dhivy $21.17Ztlido $21.03Austedo $20.40Exablate $19.08Myobloc $18.50Xadago $18.50Apokyn $18.50Gomekli $17.15Ongentys 50mg Capsules 30 $16.93Aimovig $15.24
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lucas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.